NASDAQInformation TechnologyInformation Technology ServicesSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for CSPI yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Stable leadership and management execution | The company is stable in leadership and focused on growth. | Under Pressure | Additional key executive departures within next 4 quarters | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Dec 15, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a higher-risk technology growth story, not a proven steady compounder. The multi-year view is still active, with management on track for full-year growth, but recent performance is weak and the thesis remains in a watch state.
CSPI is described as cheap versus peers, and the priced-in assessment is justified with low fragility. The expectations gap is negative, so market expectations appear cautious; valuation confidence is medium, and valuation has risen recently.
Near term, results have been weak relative to the industry cohort, while revenue for the first nine months of 2026 was below the prior-year period. Management remains on track for full-year growth, and Technology Solutions revenue grew despite hardware supply delays; AZT PROTECT deployment progress is mixed.
The multi-year thesis depends on sustained full-year growth, broader AZT PROTECT deployments, and converting backlog into revenue. A guidance cut would be a meaningful negative near term, while easing rates or stabilization among major technology peers could improve the sector backdrop.
Over the next one to three years, execution on growth and backlog conversion is the central support, but weak recent performance and high risk leave meaningful uncertainty. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A primary condition in CSP, Inc.'s published investment case. The stated target is Positive free cash flow yield and net profit by FY27. |
| Broken |
| Continued negative free cash flow and net losses beyond FY27 |
Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Achieve full year revenue growth compared to fiscal 2025 | Management aims full year growth over 2025. | Broken | Revenue growth falls below 6% YoY in FY26 | Revenue: $14.398M FY2026-Q3; GAAP. Published target: Revenue grows beyond $16.012M in Q2 2026 and sustains growth through FY26. Annual target cannot be compared with a quarterly or TTM observation. Aug 14, 202614,398,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.